PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital — Baltimore, Maryland

PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital has participated in 1 clinical trials.

Therapeutic areas: Healthy Volunteer Subjects.

Sponsors: Bioblast Pharma Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital?

PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital conducted?

PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital has 1 clinical trials on record. Their work covers Healthy Volunteer Subjects.

Is PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital accredited by Crixeo Health?

PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.